Hong Kong stock anomaly | Sanofi (01530.HK) rose by over 6%, the authorized transaction with Pfizer is expected to increase profits for the company this year, with a rich reserve of R&D pipeline.

According to the Securities Times app, Sanesco Pharma (01530.HK) rose by more than 6%, as of the time of writing, it increased by 6.48%, reaching 20.7 Hong Kong dollars, with a trading volume of 933 million Hong Kong dollars.